Published in FEBS Lett on June 28, 2014
Spin labeling and Double Electron-Electron Resonance (DEER) to Deconstruct Conformational Ensembles of HIV Protease. Methods Enzymol (2015) 0.77
Pulsed EPR characterization of HIV-1 protease conformational sampling and inhibitor-induced population shifts. Phys Chem Chem Phys (2016) 0.76
Role of Conformational Motions in Enzyme Function: Selected Methodologies and Case Studies. Catalysts (2016) 0.75
Structural analyses of 2015-updated drug-resistant mutations in HIV-1 protease: an implication of protease inhibitor cross-resistance. BMC Bioinformatics (2016) 0.75
Effects of Hinge-region Natural Polymorphisms on Human Immunodeficiency Virus-Type 1 Protease Structure, Dynamics, and Drug Pressure Evolution. J Biol Chem (2016) 0.75
NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J Biomol NMR (1995) 93.94
Dead-time free measurement of dipole-dipole interactions between electron spins. J Magn Reson (2000) 5.26
HIV-1 protease flaps spontaneously open and reclose in molecular dynamics simulations. Proc Natl Acad Sci U S A (2006) 3.30
An inhibitor of the protease blocks maturation of human and simian immunodeficiency viruses and spread of infection. Proc Natl Acad Sci U S A (1990) 2.32
Rapid structural fluctuations of the free HIV protease flaps in solution: relationship to crystal structures and comparison with predictions of dynamics calculations. Protein Sci (2002) 2.17
Curling of flap tips in HIV-1 protease as a mechanism for substrate entry and tolerance of drug resistance. Structure (2000) 2.10
HIV protease: a novel chemotherapeutic target for AIDS. J Med Chem (1991) 1.90
Domain flexibility in retroviral proteases: structural implications for drug resistant mutations. Biochemistry (1998) 1.75
Domain communication in the dynamical structure of human immunodeficiency virus 1 protease. Proc Natl Acad Sci U S A (1990) 1.61
The HIV-1 protease as enzyme and substrate: mutagenesis of autolysis sites and generation of a stable mutant with retained kinetic properties. Biochemistry (1994) 1.59
Drug resistance in HIV-1 protease: Flexibility-assisted mechanism of compensatory mutations. Protein Sci (2002) 1.54
Optimisation of NMR dynamic models I. Minimisation algorithms and their performance within the model-free and Brownian rotational diffusion spaces. J Biomol NMR (2007) 1.52
Drug pressure selected mutations in HIV-1 protease alter flap conformations. J Am Chem Soc (2009) 1.41
Solution structure of HIV-1 protease flaps probed by comparison of molecular dynamics simulation ensembles and EPR experiments. J Am Chem Soc (2008) 1.38
HIV-1 Protease: Structural Perspectives on Drug Resistance. Viruses (2009) 1.37
Conformational flexibility in the flap domains of ligand-free HIV protease. Acta Crystallogr D Biol Crystallogr (2007) 1.36
Interflap distances in HIV-1 protease determined by pulsed EPR measurements. J Am Chem Soc (2007) 1.32
Protein conformational dynamics in the mechanism of HIV-1 protease catalysis. Proc Natl Acad Sci U S A (2011) 1.25
Hydrophobic sliding: a possible mechanism for drug resistance in human immunodeficiency virus type 1 protease. Structure (2007) 1.20
HIV-1 protease with 20 mutations exhibits extreme resistance to clinical inhibitors through coordinated structural rearrangements. Biochemistry (2012) 1.20
Optimisation of NMR dynamic models II. A new methodology for the dual optimisation of the model-free parameters and the Brownian rotational diffusion tensor. J Biomol NMR (2007) 1.19
Monitoring inhibitor-induced conformational population shifts in HIV-1 protease by pulsed EPR spectroscopy. Biochemistry (2009) 1.18
Secondary mutations M36I and A71V in the human immunodeficiency virus type 1 protease can provide an advantage for the emergence of the primary mutation D30N. Biochemistry (2003) 1.15
Subtype polymorphisms among HIV-1 protease variants confer altered flap conformations and flexibility. J Am Chem Soc (2009) 1.13
Dynamics of "flap" structures in three HIV-1 protease/inhibitor complexes probed by total chemical synthesis and pulse-EPR spectroscopy. J Am Chem Soc (2009) 1.10
Solute effects on spin labels at an aqueous-exposed site in the flap region of HIV-1 protease. J Phys Chem B (2009) 1.02
Molecular dynamics of HIV-1 protease. Proteins (1992) 0.99
Differential Flap Dynamics in Wild-type and a Drug Resistant Variant of HIV-1 Protease Revealed by Molecular Dynamics and NMR Relaxation. J Chem Theory Comput (2012) 0.98
relaxGUI: a new software for fast and simple NMR relaxation data analysis and calculation of ps-ns and μs motion of proteins. J Biomol NMR (2011) 0.97
Accessory mutations maintain stability in drug-resistant HIV-1 protease. J Mol Biol (2011) 0.96
Elucidating a relationship between conformational sampling and drug resistance in HIV-1 protease. Biochemistry (2013) 0.92
Pulsed EPR distance measurements in soluble proteins by site-directed spin labeling (SDSL). Curr Protoc Protein Sci (2013) 0.90
Correlating conformational shift induction with altered inhibitor potency in a multidrug resistant HIV-1 protease variant. Biochemistry (2012) 0.88
The role of select subtype polymorphisms on HIV-1 protease conformational sampling and dynamics. J Biol Chem (2014) 0.87
Inhibitor-induced conformational shifts and ligand-exchange dynamics for HIV-1 protease measured by pulsed EPR and NMR spectroscopy. J Phys Chem B (2012) 0.84
Backbone ¹H, ¹³C, and ¹⁵N chemical shift assignment for HIV-1 protease subtypes and multi-drug resistant variant MDR 769. Biomol NMR Assign (2012) 0.82
Resolution of discordant HIV-1 protease resistance rankings using molecular dynamics simulations. J Chem Inf Model (2011) 0.81
Simple tests for the validation of multiple field spin relaxation data. J Biomol NMR (2009) 0.80